Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index; 2 of the 9 sources its claims cite were checked for support.

A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India

Open access
Patel, Punkesh, Rajendran, Vinu, Nair, Amita Radhakrishnan, Gupta, Debasish · 2026 · Asian Journal of Transfusion Science

Abstract

BACKGROUND: Donor vigilance is the monitoring of donor adverse events (DAEs) to improve donor safety and the quality of the blood donation process. This study aimed to grade and assess DAEs using a new severity grading tool (SGT) by the Hemovigilance Programme of India and to identify factors influencing it. MATERIALS AND METHODS: A single-center prospective observational study was conducted over 14 months among whole blood and apheresis donors with DAEs. Data was recorded in the Adverse Blood Donor Reaction Reporting Form-2 and supplemented with Blood Centre records. Data were compiled in Microsoft Excel and analyzed using DATAtab 2023. RESULTS: Out of 11,171 registered blood donors, 7188 were eligible for donation. The overall incidence of DAEs was 288 (4.0%), out of them 0.3% occurred in predonation, 20.5% during donation, and 79.2% in postdonation. Among the DAEs, 95.8% were Grade 1, and 4.2% were Grade 2. DAEs were significantly higher in females, first-time, and apheresis donors, with increased incidence during noon time, summer season, and outdoor camps. Generalized vasovagal reactions were the most common. CONCLUSION: Four out of 100 donors were experiencing DAE, and the majority was of Grade 1 severity. Strategies may be adopted to mitigate DAEs among those who are predisposed to DAEs. In addition, unreported delayed DAEs are of further concern for the blood center. Our study found that SGT effectively improves the objective severity grading of DAEs. Terminologies like outside medical care are less relevant in India, where most blood donors with DAEs are managed by the medical team at the blood centre.

Overview

CoChat Summary

TL;DR

This single-center prospective study graded donor adverse events (DAEs) using the Hemovigilance Programme of India severity grading tool and found an overall DAE incidence of 4.0% among 7,188 eligible donors. Most DAEs were Grade 1 and occurred postdonation, with higher rates in females, first-time donors, and apheresis donors.

Key findings

  • Among 11,171 registered donors, 7,188 were eligible; 288 DAEs occurred (4.0%). By timing, 0.3% (n = 1) were predonation, 20.5% (n = 59) during donation, and 79.2% (n = 228) postdonation.
  • Severity grading showed 95.8% (n = 276) Grade 1 and 4.2% (n = 12) Grade 2; imputability was “Definite” for 99.3% (n = 286) and “Probable” for 0.7% (n = 2).
  • DAEs were significantly higher in females (7.2%) than males (3.4%), first-time donors (6.8%) than repeat donors (2.5%, P < 0.001), and outdoor camps (5.0%) than the Blood Centre (2.5%).
  • Generalized vasovagal reactions were most common; VVR incidence among platelet apheresis donors was 18.2%, and vasovagal DAEs were higher in summer months February–April (P = 0.0053).

Methods

  • Single-center prospective observational study conducted over 14 months (June 2022–July 31, 2023) among whole blood and apheresis donors at a tertiary care hospital-based blood center.
  • Data were recorded in the Adverse Blood Donor Reaction Reporting Form-2 and supplemented with Blood Centre records; donors were followed up for 2 weeks to monitor complications.
  • Analysis used DATAtab 2023, with chi-square tests for nonparametric variables and t-tests for parametric variables in univariate analysis.

Limitations

  • The paper states that plateletpheresis collections at the center were limited and that some donors may not have reported delayed DAEs due to confusion or misunderstanding despite thorough explanation.
  • The text makes evident that delayed DAEs may be undercounted because reporting depended on donor callback/follow-up, and the authors note unreported delayed DAEs remain a concern for blood centers.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.4103/ajts.ajts_154_24

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Overall methodology followed in the study. DAEs: Donor adverse events, ABDRRF-2: Adverse Blood Donor Reaction Reporting Form-2
Figure 1 Overall methodology followed in the study. DAEs: Donor adverse events, ABDRRF-2: Adverse Blood Donor Reaction Reporting Form-2CC BY-NC-SA · PubMed Central
Figure 2 Reported donor adverse events during the blood donation process, i.e., predonation, during donation, and postdonation. DAEs: Donor adverse events, WB: Whole blood
Figure 2 Reported donor adverse events during the blood donation process, i.e., predonation, during donation, and postdonation. DAEs: Donor adverse events, WB: Whole bloodCC BY-NC-SA · PubMed Central
Figure 3 Diurnal variation in the incidence of donor adverse events. DAEs: Donor adverse events
Figure 3 Diurnal variation in the incidence of donor adverse events. DAEs: Donor adverse eventsCC BY-NC-SA · PubMed Central
Figure 4 Distribution of the various types of donor adverse events
Figure 4 Distribution of the various types of donor adverse eventsCC BY-NC-SA · PubMed Central
Figure 5 (a) Hematoma at venipuncture site before and after management, (b) Extension of hematoma
Figure 5 (a) Hematoma at venipuncture site before and after management, (b) Extension of hematomaCC BY-NC-SA · PubMed Central
Figure 6 Association between the timing of the last meal and vasovagal donor adverse events. DAEs: Donor adverse events
Figure 6 Association between the timing of the last meal and vasovagal donor adverse events. DAEs: Donor adverse eventsCC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

2 Valid · 0 Not valid · 7 Not checked · 45 Own results and interpretations

32 more claims

Create a free account to see all 54 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 10
  • Probably not a substantial claim. 10

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

1 of 1

Citations

Cites

Show all 18 references

Research works printed but not linked: 2

  1. Das, 2016, Hemovigilance: An institutional study, Int J Sci Res, 5, 203
  2. Rai, 2018, Adverse reaction in whole blood donors at a tertiary care Centre, Gwalior, IOSR J Dent Med Sci, 17, 31

Metadata

Authors
Patel, P., Rajendran, V., Nair, A. R., & Gupta, D.
Affiliations
Sree Chitra Thirunal Institute for Medical Sciences and Technology (IN)
Corresponding author
Gupta, Debasish
Venue
Asian Journal of Transfusion Science
Published
2025-09-05
Volume
20
Issue
1
Pages
50-57
ISSN
  • 0973-6247 (ISSN-L)
  • 1998-3565
OpenAlex
W7082630150
Cited by
0
References
18
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Asian Journal of Transfusion Science (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • PubMed Central (submittedVersion, cc-by-nc-sa)
Topics
  • Health Sciences › Medicine › Hematology › Blood donation and transfusion practices
  • Health Sciences › Medicine › Hematology › Blood transfusion and management
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
hemovigilance, blood donor safety, apheresis donors, whole blood donors, risk factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India. https://app.cochat.ai/papers/10.4103/ajts.ajts_154_24
The paper
Patel, P., Rajendran, V., Nair, A. R., & Gupta, D. (2026). A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India. Asian Journal of Transfusion Science. https://doi.org/10.4103/ajts.ajts_154_24

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.